F. Hoffmann-La Roche is a Switzerland-based healthcare company spanning pharmaceuticals and diagnostics. Founded in Basel in 1896, Roche has grown into the world’s largest biotechnology company and a global leader in in-vitro diagnostics.
Over 20 pharmaceutical companies are developing therapies for HER2-positive gastric cancer, with multiple Phase III trials launched in March 2026 testing novel combination treatments for advanced disease.
Over 10 companies are developing 12+ pipeline therapies for Neuromyelitis Optica Spectrum Disorder, including Roche's satralizumab Phase III pediatric trial and multiple anti-CD20 monoclonal antibody candidates.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07749157 |
A Study of Subcutaneously Administered RO7845860 in Participants With Relapsing Multiple Sclerosis |
NOT_YET_RECRUITING | PHASE1 |
| NCT07748208 |
A Study Evaluating the Safety of Inavolisib and Fulvestrant With or Without Palbociclib in Participants With Advanced Breast Cancer (ABC) and Type 2 Diabetes |
NOT_YET_RECRUITING | PHASE2 |
| NCT07741604 |
A Study Investigating the Safety of RO7795081 and How the Body Processes RO7795081 in People With Normal or Decreased Kidney Functions |
NOT_YET_RECRUITING | PHASE1 |
| NCT07717411 |
A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease |
NOT_YET_RECRUITING | PHASE3 |
| NCT07681167 |
Faricimab for Chronic Central Serous Chorioretinopathy: A Randomized Sham-Controlled Trial |
NOT_YET_RECRUITING | PHASE2 |
| NCT07670416 |
A Study to Evaluate the Effects of Enicepatide in Participants With Obesity or Overweight, With or Without Type 2 Diabetes |
RECRUITING | PHASE3 |
| NCT07667322 |
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of a New Subcutaneous Formulation of Ocrelizumab in Participants With Multiple Sclerosis |
ACTIVE_NOT_RECRUITING | PHASE1 |
| NCT07665723 |
An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative Colitis |
RECRUITING | PHASE1 |
| NCT07634289 |
Radiotherapy in Combination With Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma |
NOT_YET_RECRUITING | PHASE2 |
| NCT07626515 |
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Enicepatide in Generally Healthy Adult Chinese Participants |
RECRUITING | PHASE1 |
